Back to Results
First PageMeta Content
Anatomy / Botulinum toxin / Blepharospasm / Spasmodic torticollis / Dystonia / Spasticity / Focal dystonia / Neurotoxin / Neurological disorders / Medicine / Biology


5.7 INCOBOTULINUMTOXIN A, powder for solution for injection, 100LD50 units, Xeomin®, Merz Pharmaceuticals GmbH. Purpose of Application
Add to Reading List

Document Date: 2015-04-22 23:39:46

Open Document

File Size: 107,30 KB

Share Result on Facebook

City

Dysport / /

Company

Merz Pharmaceuticals GmbH / Botox / The AEs / /

Country

Australia / /

Currency

USD / /

Event

FDA Phase / /

MarketIndex

Blepharospasm Disability / /

MedicalCondition

abnormal movements / established severe contracture / contracture / cervical dystonia / dysphagia / blepharospasm / stroke / back pain / contraction / treatment effect Blepharospasm / focal dystonia / disorders / therapy Cervical dystonia / /

MedicalTreatment

physiotherapy / adjunctive therapy / physical therapy / /

OperatingSystem

BSDI / /

/

Position

investigator / head / neck and shoulders / nurse / /

Product

XEOMIN® / /

Technology

pharmacokinetics / Trial ID Protocol / /

SocialTag